|
| Protein Name | Mitogen-Activated Protein Kinase 3 |
| Gene | MAPK3 |
| UniProt | P27361 |
| Molecular Weight | ~43 kDa |
| Subcellular Localization | Cytoplasm, Nucleus |
| Protein Family | MAP kinase family, CMGC group |
| Aliases | ERK1, p44 MAP Kinase, p44erk |
MAPK3, also known as ERK1 (Extracellular Signal-Regulated Kinase 1), is a serine/threonine protein kinase encoded by the MAPK3 gene. It belongs to the MAP kinase family and plays critical roles in cellular signal transduction, gene expression regulation, cell proliferation, and neuronal function. The MAPK/ERK pathway is one of the most important signaling cascades in the nervous system, regulating synaptic plasticity, memory formation, and neuronal survival. Dysregulation of MAPK3 signaling is implicated in the pathogenesis of Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders [1].
MAPK3 (ERK1) has the typical MAP kinase domain organization:
¶ Kinase Domain
- N-terminal kinase domain (~300 residues
- Contains the characteristic DF/LYXXXXF motif
- ATP-binding site in the cleft
- Contains the TEY (Thr-Glu-Tyr) dual phosphorylation motif
- Thr202 and Tyr204 are phosphorylated for activation
- Phosphorylation by MEK1/2 activates the kinase
- Common docking (CD) domain for substrate selection
- FERP (FXXP/FR) motif for interactions
- Overall 83% identity to ERK2
- Longer N-terminal region than ERK2
- Forms dimers upon activation
MAPK3/ERK1 is a central node in cellular signaling:
- MAP kinase cascade: Activated by Ras-Raf-MEK-ERK
- Growth factor signaling: Responds to BDNF, NGF, EGF
- Cell surface to nucleus: Transduces extracellular signals
In neurons, MAPK3 has critical roles:
Synaptic plasticity:
Neuronal development:
- Neuronal differentiation
- Axonal guidance
- Dendrite morphogenesis
Neuroprotection:
- Responses to neurotrophic factors
- Anti-apoptotic signaling
- Stress adaptation
ERK1 phosphorylates transcription factors:
- ELK-1, c-Fos, c-Myc
- CREB
- Stat proteins
MAPK3 is implicated in AD pathogenesis:
Tau pathology:
- Co-localizes with neurofibrillary tangles [2]
- Can phosphorylate tau at multiple sites
- May contribute to tau hyperphosphorylation
Amyloid-β signaling:
- Aβ activates MAPK3/ERK1 pathway
- May mediate Aβ-induced toxicity
- Complex role in Aβ responses
Synaptic dysfunction:
- Altered ERK signaling in AD brains
- Contributes to synaptic plasticity deficits
- Memory impairment mechanisms
MAPK3 involvement in PD:
Dopaminergic neuron survival:
- Neurotrophin signaling in substantia nigra
- Responses to stress
- Altered in PD models
α-Synuclein pathology:
- ERK activation in Lewy bodies
- May respond to α-synuclein aggregation
- Complex role in neurodegeneration
Neuroinflammation:
- Activated in microglia
- May contribute to neuroinflammation
¶ Stroke and Brain Injury
- Activated by ischemia
- Both protective and damaging roles
- Potential therapeutic target
- Depression: ERK signaling in mood disorders
- Addiction: Reward pathway signaling
- Multiple sclerosis: Demyelination signaling
MAPK3 is a therapeutic target:
- MEK inhibitors (upstream blockers)
- Direct ERK inhibitors (in development)
- BDNF mimetics
- TrkB agonists
- Targeting downstream effectors
- Substrate-specific inhibitors
Key findings:
- ERK1/2 have overlapping but distinct functions
- Genetic deletion of ERK1 enhances memory
- ERK2 more critical for development